Evidence map›Paper›PMID 37662304›Full record

ArticlebioRxiv : the preprint server for biology2023

Innate immune control of influenza virus interspecies adaptation.

Parker J Denz, Samuel Speaks, Adam D Kenney, Adrian C Eddy, Jonathan L Papa, Jack Roettger, Sydney C Scace, Emily A Hemann, Adriana Forero, Richard J Webby and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Parker J DenzDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Samuel SpeaksDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Adam D KenneyDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Adrian C EddyDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Jonathan L PapaDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Jack RoettgerDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Sydney C ScaceDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Emily A HemannDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Adriana ForeroDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Richard J WebbyDepartment of Infectious Diseases, St. Jude Children's Research Hospital; Memphis, TN, USA.
Andrew S BowmanViruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University; Columbus, OH, USA.
Jacob S YountDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine; Columbus, OH, USA.
Columbus Oncology and Hematology Associates · USSt. Jude Children's Research Hospital · US

Funding

Mechanisms of innate resistance to virus infectionsR01AI130110 · NIAID · OHIO STATE UNIVERSITY · PI Jacob Yount · 2017 to 2026
$4.3M
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITYR01AI159452 · NIAID · OHIO STATE UNIVERSITY · PI AMER, AMAL O, SEVEAU, STEPHANIE M M · 2021 to 2025
$3.7M
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infectionsR01HL168501 · NHLBI · OHIO STATE UNIVERSITY · PI Amal O Amer, Jacob Yount · 2023 to 2026
$2.9M
Protein therapy to treat virus induced cardiopulmonary injuryR01HL157215 · NHLBI · UNIVERSITY OF VIRGINIA · PI CAI, CHUANXI, MA, JIANJIE · 2022 to 2025
$2.7M
Mechanistic characterization of a new master regulator of cardiac virus infectionsR01HL154001 · NHLBI · OHIO STATE UNIVERSITY · PI ACCORNERO, FEDERICA, YOUNT, JACOB · 2020 to 2023
$2.3M
Interdisciplinary Program in Microbe-Host BiologyT32AI165391 · NIAID · OHIO STATE UNIVERSITY · PI RAJENDAR K DEORA, Daniel J Wozniak · 2022 to 2026
$1.5M
Interdisciplinary Program in Microbe-Host BiologyT32AI112542 · NIAID · OHIO STATE UNIVERSITY · PI JUSTICE, SHERYL S, WOZNIAK, DANIEL J · 2014 to 2018
$644k
Establishing a relevant mouse model with susceptibility to non-adapted influenza viruses for vaccine challenge studiesR21AI151230 · NIAID · OHIO STATE UNIVERSITY · PI YOUNT, JACOB · 2020 to 2021
$409k
Mechanisms of Interferon-Lambda Programming at the Innate-Adaptive Immune Interface for Protection Against Virus InfectionK22AI146141 · NIAID · OHIO STATE UNIVERSITY · PI HEMANN, EMILY ANN · 2021 to 2022
$268k
NHLBI NIH HHS R01 HL154001NHLBI NIH HHS R01 HL157215NHLBI NIH HHS R01 HL168501NIAID NIH HHS K22 AI146141NIAID NIH HHS R01 AI130110NIAID NIH HHS R01 AI159452NIAID NIH HHS R21 AI151230NIAID NIH HHS T32 AI112542NIAID NIH HHS T32 AI165391
6 · The paper itself

Abstract

Influenza virus pandemics are caused by viruses from animal reservoirs that adapt to efficiently infect and replicate in human hosts. Here, we investigated whether Interferon-Induced Transmembrane Protein 3 (IFITM3), a host antiviral factor with known human deficiencies, plays a role in interspecies virus infection and adaptation. We found that IFITM3-deficient mice and human cells could be infected with low doses of avian influenza viruses that failed to infect WT counterparts, identifying a new role for IFITM3 in controlling the minimum infectious viral dose threshold. Remarkably, influenza viruses passaged through

Identifiers

PMID37662304
PMCPMC10473703
OpenAlexW4386140825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.